Genomictree Inc (228760)

Currency in KRW
14,000
-370(-2.57%)
Closed·
228760 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 13 days
Fair Value
Day's Range
13,88014,250
52 wk Range
11,39024,500
Key Statistics
Bid/Ask
14,000.00 / 14,060.00
Prev. Close
14,370
Open
14,250
Day's Range
13,880-14,250
52 wk Range
11,390-24,500
Volume
75.29K
Average Volume (3m)
110.45K
1-Year Change
-32.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
228760 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Genomictree Inc Company Profile

Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients. It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

Compare 228760 to Peers and Sector

Metrics to compare
228760
Peers
Sector
Relationship
P/E Ratio
−32.0x−9.0x−0.5x
PEG Ratio
−1.34−0.130.00
Price/Book
2.8x2.8x2.6x
Price / LTM Sales
140.4x33.1x3.2x
Upside (Analyst Target)
-0.0%41.7%
Fair Value Upside
Unlock−0.4%6.1%Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-121.00 / --
Revenue / Forecast
316.49M / 7.00B
EPS Revisions
Last 90 days

228760 Income Statement

FAQ

What Stock Exchange Does Genomictree Trade On?

Genomictree is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Genomictree?

The stock symbol for Genomictree is "228760."

What Is the Genomictree Market Cap?

As of today, Genomictree market cap is 336.06B.

What Is Genomictree's Earnings Per Share (TTM)?

The Genomictree EPS (TTM) is -432.67.

When Is the Next Genomictree Earnings Date?

Genomictree will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 228760 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Genomictree Stock Split?

Genomictree has split 2 times.

How Many Employees Does Genomictree Have?

Genomictree has 0 employees.

What is the current trading status of Genomictree (228760)?

As of 26 Jul 2025, Genomictree (228760) is trading at a price of 14,000.00, with a previous close of 14,370.00. The stock has fluctuated within a day range of 13,880.00 to 14,250.00, while its 52-week range spans from 11,390.00 to 24,500.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.